Grupo Español De Linfomas Y Transplante Autólogo De Médula Ósea
Clinical trials sponsored by Grupo Español De Linfomas Y Transplante Autólogo De Médula Ósea, explained in plain language.
-
New hope for lymphoma patients: chemo-free combo shows promise
Disease control Recruiting nowThis study tests a combination of two drugs, pirtobrutinib and rituximab, in people with a slow-growing form of mantle cell lymphoma who have not had treatment before. The goal is to see if this drug pair can shrink or control the cancer without using standard chemotherapy. About…
Phase: PHASE2 • Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea • Aim: Disease control
Last updated May 17, 2026 08:16 UTC
-
CAR T-Cell therapy takes on late lymphoma relapse in new trial
Disease control Recruiting nowThis study tests a treatment called axicabtagene ciloleucel, a type of CAR T-cell therapy, in 45 adults with diffuse large B-cell lymphoma that has come back after a long period. The goal is to see if the therapy can make the cancer disappear on scans three months after treatment…
Phase: PHASE2 • Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea • Aim: Disease control
Last updated May 17, 2026 08:01 UTC